Interpreting the evidence from tolvaptan clinical trials

Toshikazu Tanaka; Masataka Kawana; Shun Kohsaka

doi:10.1016/j.jjcc.2019.02.018

Interpreting the evidence from tolvaptan clinical trials

Toshikazu Tanaka, Masataka Kawana, Shun Kohsaka

Department of Internal Medicine (Cardiology)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	195
Number of pages	1
Journal	Journal of Cardiology
Volume	74
Issue number	2
DOIs	https://doi.org/10.1016/j.jjcc.2019.02.018
Publication status	Published - 2019 Aug

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jjcc.2019.02.018

Cite this

@article{a87ae026951d43ff8bfc69efa2e8e06f,

title = "Interpreting the evidence from tolvaptan clinical trials",

author = "Toshikazu Tanaka and Masataka Kawana and Shun Kohsaka",

year = "2019",

month = aug,

doi = "10.1016/j.jjcc.2019.02.018",

language = "English",

volume = "74",

pages = "195",

journal = "Journal of Cardiology",

issn = "0914-5087",

number = "2",

}

TY - JOUR

T1 - Interpreting the evidence from tolvaptan clinical trials

AU - Tanaka, Toshikazu

AU - Kawana, Masataka

AU - Kohsaka, Shun

PY - 2019/8

Y1 - 2019/8

UR - http://www.scopus.com/inward/record.url?scp=85066756974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066756974&partnerID=8YFLogxK

U2 - 10.1016/j.jjcc.2019.02.018

DO - 10.1016/j.jjcc.2019.02.018

M3 - Letter

C2 - 30948184

AN - SCOPUS:85066756974

VL - 74

SP - 195

JO - Journal of Cardiology

JF - Journal of Cardiology

SN - 0914-5087

IS - 2

ER -

Interpreting the evidence from tolvaptan clinical trials

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this